P. August et al., COMPARATIVE RENAL HEMODYNAMIC-EFFECTS OF LISINOPRIL, VERAPAMIL, AND AMLODIPINE IN PATIENTS WITH CHRONIC-RENAL-FAILURE, American journal of hypertension, 6(4), 1993, pp. 148-154
We investigated the effects of lisinopril, verapamil, and amlodipine i
n 26 hypertensive patients with chronic renal disease of varying etiol
ogies. Blood pressure, urine protein excretion, glomerular filtration
rate (GFR), and renal blood flow (RBF) (inulin and para-aminohippurate
clearance) were determined before and after 2 to 3 months of therapy.
All three agents lowered blood pressure with minimal side effects in
many, but not all, patients. Patients who had a significant lowering o
f blood pressure in response to lisinopril and verapamil had favorable
renal hemodynamic responses as well - GFR remained stable, RBF was st
able or increased, and filtration fraction, renal vascular resistance,
and proteinuria tended to decrease. Patients whose blood pressure did
not decrease had less favorable responses. In the small number of pat
ients who received amlodipine, lowering of blood pressure was associat
ed with a small decrease in GFR. Our results demonstrate a heterogenei
ty in response to antihypertensive agents in patients with renal disea
se. We therefore conclude that treatment of such patients should be in
dividualized, and suggest that choice of therapy depend on adequate bl
ood pressure response in conjunction with stabilization of renal funct
ion and urine protein excretion. Our data do not support the use of a
drug in these circumstances if it does not lower systemic blood pressu
re.